← Open Payments lookup

MICHAEL SINFUEGO: Open Payments

NPI 1174235451 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$570 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $570

Food & beverage: $570
CompanyPaymentsAmount
Amgen Inc.10$169
AstraZeneca Pharmaceuticals LP6$143
Novo Nordisk Inc2$47
Calliditas Therapeutics US Inc.1$28
Ascendis Pharma Endocrinology Inc1$28
ANI Pharmaceuticals, Inc.1$28
Lilly USA, LLC1$24
Aurinia Pharma U.S., Inc.1$23
GlaxoSmithKline, LLC.1$23
Travere Therapeutics, Inc.1$20

Products named: LOKELMA, KRYSTEXXA, Ozempic, TARPEYO, Yorvipath, PURIFIED CORTROPHIN GEL, REPATHA, JARDIANCE.

Industry payments across CA — which companies pay providers there.